MJMJ
Nice thought. The reality is that third world countries can get relenza for nothing as they dont abide to patents and royalties.
India is in this category. They are looking to ramp up generic relenza and pay not one cent to BTA or GSK.
We are just fortunate China seems to playing by the rules.